Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.

Zeng G, Apte U, Micsenyi A, Bell A, Monga SP.

Exp Cell Res. 2006 Nov 1;312(18):3620-30. Epub 2006 Aug 10.

PMID:
16952352
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW.

Cell. 2006 Jun 30;125(7):1253-67.

PMID:
16814713
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.

Kaposi-Novak P, Lee JS, Gòmez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS.

J Clin Invest. 2006 Jun;116(6):1582-95. Epub 2006 May 18.

PMID:
16710476
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.

Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P.

Hepatology. 2006 Mar;43(3):515-24.

PMID:
16496320
[PubMed - indexed for MEDLINE]
5.

Global cancer statistics, 2002.

Parkin DM, Bray F, Ferlay J, Pisani P.

CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

PMID:
15761078
[PubMed - indexed for MEDLINE]
6.

Preneoplastic lesions in human hepatocarcinogenesis.

Libbrecht L, Desmet V, Roskams T.

Liver Int. 2005 Feb;25(1):16-27. Review.

PMID:
15698394
[PubMed - indexed for MEDLINE]
7.

Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells.

Yant SR, Park J, Huang Y, Mikkelsen JG, Kay MA.

Mol Cell Biol. 2004 Oct;24(20):9239-47.

PMID:
15456893
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Genetic alterations in hepatocellular adenomas: recent findings and new challenges.

Zucman-Rossi J.

J Hepatol. 2004 Jun;40(6):1036-9. Review. No abstract available.

PMID:
15158349
[PubMed - indexed for MEDLINE]
9.

Reversibility of oncogene-induced cancer.

Felsher DW.

Curr Opin Genet Dev. 2004 Feb;14(1):37-42. Review.

PMID:
15108803
[PubMed - indexed for MEDLINE]
10.

Focus on hepatocellular carcinoma.

Bruix J, Boix L, Sala M, Llovet JM.

Cancer Cell. 2004 Mar;5(3):215-9. Review. No abstract available.

PMID:
15050913
[PubMed - indexed for MEDLINE]
Free Article
11.

Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families.

Reznik Y, Dao T, Coutant R, Chiche L, Jeannot E, Clauin S, Rousselot P, Fabre M, Oberti F, Fatome A, Zucman-Rossi J, Bellanne-Chantelot C.

J Clin Endocrinol Metab. 2004 Mar;89(3):1476-80.

PMID:
15001650
[PubMed - indexed for MEDLINE]
12.

Caught up in a Wnt storm: Wnt signaling in cancer.

Giles RH, van Es JH, Clevers H.

Biochim Biophys Acta. 2003 Jun 5;1653(1):1-24. Review.

PMID:
12781368
[PubMed - indexed for MEDLINE]
Free Article
13.

New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism.

Cadoret A, Ovejero C, Terris B, Souil E, Lévy L, Lamers WH, Kitajewski J, Kahn A, Perret C.

Oncogene. 2002 Nov 28;21(54):8293-301.

PMID:
12447692
[PubMed - indexed for MEDLINE]
Free Article
14.

Molecular pathogenesis of human hepatocellular carcinoma.

Thorgeirsson SS, Grisham JW.

Nat Genet. 2002 Aug;31(4):339-46.

PMID:
12149612
[PubMed - indexed for MEDLINE]
15.

Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.

Monga SP, Mars WM, Pediaditakis P, Bell A, Mulé K, Bowen WC, Wang X, Zarnegar R, Michalopoulos GK.

Cancer Res. 2002 Apr 1;62(7):2064-71.

PMID:
11929826
[PubMed - indexed for MEDLINE]
Free Article
16.

Pathways of progression in hepatocarcinogenesis.

Pitot HC.

Lancet. 2001 Sep 15;358(9285):859-60. Review. No abstract available.

PMID:
11567698
[PubMed - indexed for MEDLINE]
17.

Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice.

Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM.

J Cell Biol. 2001 May 28;153(5):1023-34.

PMID:
11381087
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.

D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA.

Nat Med. 2001 Feb;7(2):235-9.

PMID:
11175856
[PubMed - indexed for MEDLINE]
19.

u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.

Tavian D, De Petro G, Benetti A, Portolani N, Giulini SM, Barlati S.

Int J Cancer. 2000 Sep 1;87(5):644-9.

PMID:
10925356
[PubMed - indexed for MEDLINE]
20.

Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

Yant SR, Meuse L, Chiu W, Ivics Z, Izsvak Z, Kay MA.

Nat Genet. 2000 May;25(1):35-41.

PMID:
10802653
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk